...
首页> 外文期刊>Biochimica et Biophysica Acta. Gene Regulatory Mechanisms >From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models
【24h】

From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models

机译:在TDP-43和FUS功能丧失的细胞模型中从转录组水平到蛋白质水平变化

获取原文
获取原文并翻译 | 示例
           

摘要

The full definition of the physiological RNA targets regulated by TDP-43 and FUS RNA-binding proteins (RBPs) represents an important issue in understanding the pathogenic mechanisms associated to these two proteins in amyotrophic lateral sclerosis and frontotemporal dementia. In the last few years several high-throughput screenings have generated a plethora of data, which are difficult to compare due to the different experimental designs and models explored. In this study by using the Affymetrix Exon Arrays, we were able to assess and compare the effects of both TDP-43 and FUS loss-of-function on the whole transcriptome using the same human neuronal SK-N-BE cell model. We showed that TDP-43 and FUS depletion induces splicing and gene expression changes mainly distinct for the two RBPs, although they may regulate common pathways, including neuron differentiation and cytoskeleton organization as evidenced by functional annotation analysis. In particular, TDP-43 and PUS were found to regulate splicing and expression of genes related to neuronal (SEPT6, SULT4A1, TNIK) and RNA metabolism (DICER, ELAVL3/HuC, POLDIP3). Our extended analysis at protein level revealed that these changes have also impact on the protein isoform ratio and content, not always in a direct correlation with transcriptomic data. Contrarily to a loss-of-function mechanism, we showed that mutant TDP-43 proteins maintained their splicing activity in human ALS fibroblasts and experimental cell lines. Our findings further contribute to define the biological functions of these two RBPs in physiological and disease state, strongly encouraging the evaluation of the identified transcriptomic changes at protein level in neuronal experimental models. (C) 2015 Elsevier B.V. All rights reserved.
机译:TDP-43和FUS RNA结合蛋白(RBPs)调控的生理RNA靶标的完整定义是理解肌萎缩性侧索硬化症和额颞痴呆中与这两种蛋白相关的致病机制的重要问题。在最近几年中,几次高通量筛选已经产生了大量数据,由于探索的实验设计和模型不同,因此难以比较。在这项使用Affymetrix外显子阵列的研究中,我们能够使用相同的人类神经元SK-N-BE细胞模型评估和比较TDP-43和FUS功能丧失对整个转录组的影响。我们显示TDP-43和FUS耗竭诱导剪接和基因表达变化主要为两个RBPs不同,尽管它们可能调节常见的途径,包括神经元分化和细胞骨架组织,如功能注释分析所证明。特别地,发现TDP-43和PUS调节与神经元(SEPT6,SULT4A1,TNIK)和RNA代谢(DICER,ELAVL3 / HuC,POLDIP3)有关的基因的剪接和表达。我们在蛋白质水平上的扩展分析表明,这些变化也影响蛋白质同工型的比例和含量,但并不总是与转录组数据直接相关。与功能丧失机制相反,我们显示突变的TDP-43蛋白在人ALS成纤维细胞和实验细胞系中保持其剪接活性。我们的发现进一步有助于定义这两种RBP在生理和疾病状态下的生物学功能,强烈鼓励在神经元实验模型中评估蛋白质水平上已确定的转录组变化。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号